IRCT201112048299N1已完成2 期
Clinical trial of oral magnesium oxide supplementation in prevention of cisplatin-induced hypomagnesaemia in cancer patients in Rasoul Akram hospital of Tehran university of medical sciences
Oncopathology Research Center of Tehran University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 80 years（—）
- 性别
- All
入选标准
- •cancer diagnosis, beginning chemotherapy with Cisplatin drug, absence of renal disease and alcoholism, leukemia, non-consumption of drugs such as diuretics, aminoglycosides, cyclosporine and amphotericin B
- •Exclusion criteria: death before end of treatment
排除标准
- 未提供
研究者
相似试验
已完成
2 期
Effect of supplementation in treatment of patients with diabetic foot ulcerIRCT201612225623N96Kashan University of Medical Sciences70
已完成
2 期
Effect of magnesium supplementation in treatment of gestational diabetesGestational diabetes mellitus.Unspecified diabetes mellitus in pregnancy, childbirth and the puerperiumO24.9IRCT20170513033941N25Iran University of Medical Sciences40
已完成
3 期
Effect of supplementation in treatment of women with gestational diabetesGestational diabetes.Diabetes mellitus in pregnancy, unspecifiedO24.9IRCT201704235623N111Vice chancellor for research, Arak University of Medical Sciences40
已完成
3 期
Effect of magnesium supplementation in treatment of diabetic hemodialysis patientsChronic kidney diseaseHemodialysis.IRCT2017090133941N19Kashan University of Medical Sciences60
尚未招募
Unknown
Investigating the effect of oral magnesium supplementation on cognitive function, fatigue, depression, anxiety of multiple sclerosis patientsMultiple sclerosisIRCT20220101053582N2Tehran University of Medical Sciences58